Cargando…

Acknowledgment to Reviewers of Antibodies in 2021

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883883/
http://dx.doi.org/10.3390/antib11010009
_version_ 1784660033764589568
collection PubMed
description
format Online
Article
Text
id pubmed-8883883
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88838832022-03-01 Acknowledgment to Reviewers of Antibodies in 2021 Antibodies (Basel) Editorial MDPI 2022-01-26 /pmc/articles/PMC8883883/ http://dx.doi.org/10.3390/antib11010009 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Acknowledgment to Reviewers of Antibodies in 2021
title Acknowledgment to Reviewers of Antibodies in 2021
title_full Acknowledgment to Reviewers of Antibodies in 2021
title_fullStr Acknowledgment to Reviewers of Antibodies in 2021
title_full_unstemmed Acknowledgment to Reviewers of Antibodies in 2021
title_short Acknowledgment to Reviewers of Antibodies in 2021
title_sort acknowledgment to reviewers of antibodies in 2021
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883883/
http://dx.doi.org/10.3390/antib11010009
work_keys_str_mv AT acknowledgmenttoreviewersofantibodiesin2021